Back to Search Start Over

Response to the novel corona virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future

Authors :
Olayinka O. Ogunleye
Debashis Basu
Debjani Mueller
Jacqueline Sneddon
R. Andrew Seaton
Adesola F. Yinka-Ogunleye
Joshua Wamboga
Nenad Miljković
Julius C. Mwita
Godfrey Mutashambara Rwegerera
Amos Massele
Okwen Patrick
Loveline Lum Niba
Melaine Nsaikila
Wafaa M. Rashed
Mohamed Ali Hussein
Rehab Hegazy
Adefolarin A. Amu
Baffour Boaten Boahen-Boaten
Zinhle Matsebula
Prudence Gwebu
Bongani Chirigo
Nongabisa Mkhabela
Tenelisiwe Dlamini
Siphiwe Sithole
Sandile Malaza
Sikhumbuzo Dlamini
Daniel Afriyie
George Awuku Asare
Seth Kwabena Amponsah
Israel Sefah
Margaret Oluka
Anastasia N. Guantai
Sylvia A. Opanga
Tebello Violet Sarele
Refeletse Keabetsoe Mafisa
Ibrahim Chikowe
Felix Khuluza
Dan Kibuule
Francis Kalemeera
Mwangana Mubita
Joseph Fadare
Laurien Sibomana
Gwendoline Malegwale Ramokgopa
Carmen Whyte
Tshegofatso Maimela
Johannes Hugo
Johanna C. Meyer
Natalie Schellack
Enos M. Rampamba
Adel Visser
Abubakr Alfadl
Elfatih M. Malik
Oliver Ombeva Malande
Aubrey C. Kalungia
Chiluba Mwila
Trust Zaranyika
Blessmore Vimbai Chaibva
Ioana D. Olaru
Nyasha Masuka
Janney Wale
Lenias Hwenda
Regina Kamoga
Ruaraidh Hill
Corrado Barbui
Tomasz Bochenek
Amanj Kurdi
Stephen Campbell
Antony P. Martin
Thuy Nguyen Thi Phuong
Binh Nguyen Thanh
Brian Godman
Source :
Frontiers in Pharmacology, Vol 11 (2020), Frontiers in Pharmacology, FRONTIERS IN PHARMACOLOGY
Publication Year :
2020

Abstract

Background The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa. Objective Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups. Our approach Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel. Ongoing activities Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality. Conclusion There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.

Details

Language :
English
ISSN :
16639812
Database :
OpenAIRE
Journal :
Frontiers in Pharmacology, Vol 11 (2020), Frontiers in Pharmacology, FRONTIERS IN PHARMACOLOGY
Accession number :
edsair.doi.dedup.....d7ea906ba85b0bceca5220d655649d0e